WinDNA helps companies move wellness from a cost line to a strategic advantage — with clinician-led genetic insight, enterprise-grade privacy, and measurable engagement.
India Inc. is quietly rewriting its benefits contract. Preventive care is replacing reactive cover, and leadership teams are asking harder questions of every wellness rupee.
Diabetes, cardiovascular risk and metabolic conditions are surfacing earlier in urban workforces — well before traditional screening cycles catch them.
CFOs and CHROs want wellness spend that is measurable, differentiated and retention-positive — not another transactional checkup package.
Employee health data now carries regulatory weight. Companies need a partner whose privacy posture is enterprise-grade by design, not by exception.
Not a screening vendor. Not a wellness app. A dedicated preventive-genomics partner with the clinical depth and delivery discipline of enterprise-grade health infrastructure.
Reports reviewed and interpreted by qualified clinicians and counsellors — never auto-generated. Employees leave with a plan, not a PDF.
From briefing to sample, report, counselling and follow-up — a single, coherent journey your HR and wellness teams don’t have to stitch together.
Home sample collection, clear communication and calm clinical framing drive meaningful uptake — without mandates or pressure.
Logistics, multilingual comfort, clinical oversight and reporting workflows designed for Indian corporate realities — not retrofitted from abroad.
Procurement-friendly by design — scoped, staged and reportable at every step, with named owners on both sides.
Workforce profile, objectives and privacy posture agreed. Cohort size, delivery model and success metrics defined upfront.
Guided home sample collection, laboratory processing and clinician-reviewed reports delivered directly to each employee — confidentially.
1:1 counselling for employees and an aggregated, privacy-safe readout for leadership — never individual data, only programme signal.
What a well-run preventive-genomics programme tends to influence — framed for CFO, CHRO and CEO conversations, not marketing decks.
Earlier awareness of metabolic and cardiovascular risk supports lifestyle and clinical pathways that reduce unplanned absences over time.
Preventive genomics tells prospective and current employees that leadership takes long-term wellbeing — not just coverage — seriously.
Clinical framing and a guided experience drive higher opt-in than standard checkup drives — without compulsion or pressure.
Aggregated programme signals — participation, cohort health themes, trend direction — suitable for leadership and ESG-style disclosures.
Most corporate wellness offerings were designed to check a box. WinDNA was designed to sit inside the benefits strategy of serious Indian employers — and to hold up under clinical, legal and leadership scrutiny.
Employee health data is handled with the seriousness it deserves. Nothing about the programme asks leadership to compromise on data posture.
Individual genetic data belongs to the employee. Employers never receive identifiable reports.
Consent, purpose limitation and data-handling designed to sit inside India’s evolving data-protection framework.
Leadership readouts are aggregated and anonymised — only cohort-level trends, never individual records.
Data is not sold, not used for advertising and not shared with third parties outside the clinical workflow.
Whether you are shaping a pilot, renewing an annual benefits cycle or structuring a multi-year partnership — there is a clean way in.
Built in India, delivered with clinical integrity. Designed for leaders who want workforce health to stand up to scrutiny — from the board, from the regulator, and from the people it is meant to serve.